XML 50 R40.htm IDEA: XBRL DOCUMENT v3.24.2.u1
INVESTMENTS - Contingent Consideration Measured at Fair Value (Details) - Contingent Consideration
$ in Thousands
9 Months Ended
Jun. 30, 2024
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]  
Beginning Balance $ 7,976
Expenses recorded due to changes in fair value 136
Cash payment of contingent consideration associated with the ID R&D acquisition (4,641)
Issuance of common stock as contingent consideration associated with the ID R&D acquisition (3,471)
Ending Balance $ 0